NASDAQ:STOK

Stoke Therapeutics Stock Insider Trading

etoro logo Buy STOK
*Your capital is at risk
$29.46
+0.780 (+2.72%)
At Close: Jun 03, 2026

Stoke Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -9.25. In total, the insiders bought 1.18M and sold 143.12K STOK shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-9.25
Buy 1.18M shares
Sell 143.12K shares
47% Buy Activity
Negligible or No Correlation
Buy Signal Low Confidence
Feb 17, 2026

Analysis Breakdown:

  • Weakened by a contradictory negative Insider Power Score.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Dec 05, 2025
Sell
Common Stock
S-Sale
Ticho Barry
Chief Medical Officer
Officer 1 989
Value: $62.3K
Dec 05, 2025
Sell
Common Stock
S-Sale
Ticho Barry
Chief Medical Officer
Officer 1 673
Value: $52.4K
Dec 05, 2025
Sell
Common Stock
S-Sale
Kaye Edward M. Md
Director
Director 500
Value: $15.9K
Dec 05, 2025
Sell
Common Stock
S-Sale
Allan Jonathan
General Counsel & Corp Sec
Officer 1 004
Value: $31.5K
Dec 05, 2025
Sell
Common Stock
S-Sale
Allan Jonathan
General Counsel & Corp Sec
Officer 5 437
Value: $169.0K
Dec 05, 2025
Sell
Common Stock
S-Sale
Allan Jonathan
General Counsel & Corp Sec
Officer 2 344
Value: $74.4K
Dec 04, 2025
Sell
Common Stock
S-Sale
Kaye Edward M. Md
Director
Director 1 231
Value: $38.6K
Dec 04, 2025
Sell
Common Stock
S-Sale
Kaye Edward M. Md
Director
Director 5 222
Value: $160.6K
Dec 04, 2025
Sell
Common Stock
S-Sale
Ticho Barry
Chief Medical Officer
Officer 323
Value: $10.1K
Dec 04, 2025
Sell
Common Stock
S-Sale
Ticho Barry
Chief Medical Officer
Officer 1 373
Value: $42.2K
Dec 04, 2025
Sell
Common Stock
S-Sale
Allan Jonathan
General Counsel & Corp Sec
Officer 824
Value: $25.3K
Dec 04, 2025
Sell
Common Stock
S-Sale
Allan Jonathan
General Counsel & Corp Sec
Officer 194
Value: $6K
Dec 03, 2025
Buy
Common Stock
M-Exempt
Kaye Edward M. Md
Director
Director 26 250
Value: $812.7K
Dec 03, 2025
Buy
Performance Stock Units
M-Exempt
Ticho Barry
Chief Medical Officer
Officer 10 000
Value: $309.6K
Dec 03, 2025
Buy
Common Stock
M-Exempt
Ticho Barry
Chief Medical Officer
Officer 10 000
Value: $309.6K
Dec 03, 2025
Buy
Performance Stock Units
M-Exempt
Kaye Edward M. Md
Director
Director 26 250
Value: $812.7K
Dec 03, 2025
Buy
Common Stock
M-Exempt
Allan Jonathan
General Counsel & Corp Sec
Officer 6 000
Value: $185.8K
Dec 03, 2025
Buy
Performance Stock Units
M-Exempt
Allan Jonathan
General Counsel & Corp Sec
Officer 6 000
Value: $185.8K
Dec 03, 2025
Sell
Common Stock
S-Sale
Ticho Barry
Chief Medical Officer
Officer 789
Value: $23.9K
Dec 02, 2025
Sell
Common Stock
S-Sale
Ticho Barry
Chief Medical Officer
Officer 762
Value: $23.0K
Dec 02, 2025
Sell
Common Stock
S-Sale
Ticho Barry
Chief Medical Officer
Officer 1 244
Value: $36.8K
Dec 02, 2025
Sell
Common Stock
S-Sale
Kaye Edward M. Md
Director
Director 661
Value: $19.5K
Dec 01, 2025
Buy
Common Stock
M-Exempt
Ticho Barry
Chief Medical Officer
Officer 11 981
Value: $360.5K
Dec 01, 2025
Buy
Restricted Stock Units
M-Exempt
Ticho Barry
Chief Medical Officer
Officer 11 981
Value: $360.5K
Dec 01, 2024
Buy
Common Stock
M-Exempt
Kaye Edward M. Md
Director
Director 4 317
Value: $127.2K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT STOKE THERAPEUTICS, INC.
Stoke Therapeutics
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. Its lead clinical candidate is STK-001, which is in phase I/IIa clinical trial to treat Dravet syndrome,...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE